GLP Analogs
GLP-1 (SM) Research Peptide
A synthetic GLP-1 receptor agonist peptide referenced in published in-vitro receptor-binding studies. Laboratory reference compound. For research use only.
$59.99 — 5mg vial
| Purity | ≥99% |
| Quantity | 5mg |
| Molecular Weight | 4113.58 g/mol |
| Sequence | His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γGlu-miniPEG-γGlu-C18 diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
| Category | GLP Analogs |
| Latest batch tested | 06/19/26 |
GLP-1 (SM) in Research
GLP-1 (SM) is a synthetic single-receptor incretin analog studied for GLP-1 receptor agonism in vitro — glucose-dependent insulin-secretion signaling, glucagon suppression, and receptor-binding kinetics. Its acylated side chain, which drives albumin association in the published literature, makes it a standard reference molecule for long-acting incretin-receptor research.
Supplied lyophilized at 5mg per vial and ≥99% purity with batch-specific third-party COA documentation. It anchors the single-receptor end of our GLP analog comparison series alongside GLP-2 (TZ) and GLP-3 (RT).
Research Overview
- Investigated for glucose-dependent insulin secretion and glucagon suppression
- Studied for hypothalamic satiety center modulation and appetite regulation
- Research into cardiovascular risk reduction and anti-atherogenic properties
- Explored for GLP-1R-mediated neuroprotection and neuroinflammation reduction
- Preclinical pharmacokinetic profiling demonstrating extended half-life (~7 days)
Quality & Testing
Every GLP-1 (SM) batch is verified by independent third-party HPLC and mass-spectrometry testing, with a batch-specific certificate of analysis available on the COA page.
Laboratory Handling & Storage
Lyophilized peptides are supplied as a freeze-dried powder and are most stable stored cold (2–8°C), protected from light and moisture, in the original sealed vial. Under these conditions the research literature generally reports multi-year integrity for dry peptide material.
Once reconstituted in a laboratory setting, solutions are typically stored refrigerated and used within the window appropriate to the diluent and compound; repeated freeze–thaw cycles are avoided because they can promote aggregation. See our research overview on reconstitution and lyophilization for the underlying formulation science.
GLP-class analogs carry fatty-acid side chains; laboratory protocols typically allow reconstituted solutions to dissolve undisturbed rather than shaking.
Frequently Asked Questions
What is GLP-1 (SM)?
GLP-1 (SM) is Aurum's catalog designation for a synthetic GLP-1 receptor agonist peptide supplied as an in-vitro receptor-pharmacology reference compound.
What research is this compound used in?
Published work centers on GLP-1 receptor binding kinetics, glucose-dependent insulin-secretion signaling in cell models, and comparative incretin pharmacology against multi-receptor analogs.
Is GLP-1 (SM) for human use?
No. This material is strictly for laboratory research. It is not a pharmaceutical product, and no human application is described or endorsed.